JAK2 and acute lymphoblastic leukemia: Flow cytometry and 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays showed that proliferation suppression, increased apoptosis and cell cycle arrest in the G2/M phase occurred in the T-ALL cell lines with a JAK2 gene copy gain.